ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SKP Skyepharma

443.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skyepharma LSE:SKP London Ordinary Share GB00B3BFNB64 ORD 100P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 443.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Skyepharma Share Discussion Threads

Showing 53226 to 53249 of 53550 messages
Chat Pages: Latest  2130  2129  2128  2127  2126  2125  2124  2123  2122  2121  2120  2119  Older
DateSubjectAuthorDiscuss
23/12/2015
08:36
Well, breakout on........ :)
soundbuy
23/12/2015
07:11
What a company. 400p not too far away with this news
gersemi
22/12/2015
17:07
looks like it !!
pooroldboy55
22/12/2015
16:43
Santa rally??
cap160
21/12/2015
13:40
Hoping for a Santa rally to edge us up further!!!!
cap160
16/12/2015
16:36
Another solid day, should new highs before Xmas.
diesel
15/12/2015
16:45
Interesting that PCRX will also be able to launch for post surgical applications in oral surgery - that is a HUGE market!

I can understand the reaction in share price for PCRX - i'm now annoyed that i didn't confirm my buy options in the low 40s. Each time the trigger was reached i backed off as i was unsure how the FDA litigation process would pan out. As i trade on margin that would have been around a 4-fold gain for any margin. :-(

I have a few SKP and an initial target of 375 (the year high) for closing the trade. This could be reached quite fast as the news filters through to the mainstream. Any shortfall in the 2015 numbers as a result of the missing $8m milestone will be recouped in 2016 and we might well see a big jump in sales from late 2016 with the new indication launch...that $500m milestone is now well and truly back on the horizon.

regards,

Paul

polaris
15/12/2015
15:32
Pacira up nearly 10 dollars 15% on news.
cap160
15/12/2015
10:57
That is good news in EXPAREL and does not limit the usage in any way. Reading the wording of the various letters seems to be a success for PCRX. I hope they now find a way forward with the resubmission for the secondary indication that was rejected earlier in the year. 2016 should now see the $250m milestone reached and if they can get the secondary resubmitted on a fast track approval that may still some in early 2017.

regards,

Paul

edit
In fact it looks like the FDA resolution letter covers this indication and it will be approved for the secondary indication of nerve block as well. Bargain!

polaris
15/12/2015
10:20
That explains the interest this am, this has been in the doldrums since this fiasco started, onwards and upwards...
diesel
15/12/2015
10:18
Cheers Cap160
soundbuy
15/12/2015
10:06
Pacira have reached an amicable solution with the FDA over labelling issue with Exparel. See post on iii by Ambiorix1
cap160
09/12/2015
10:51
Someone must have picked that lot up straight away.
kfp
09/12/2015
09:50
well there's been something depressing the share price here, positive updates , positive analyst reports and we have been stuck in a channel, time will tell....
diesel
09/12/2015
09:36
Positive effect--overhang
cap160
09/12/2015
09:30
Whoa big disposal!!
cap160
07/12/2015
12:19
...and just after I sold 20,000+ earlier this morning! At least I got 325 for some of them. Needed to sell to transfer from pension to trading account so hope there isn't much upward movement until I can buy back. I want to hold SKP at least until COPD trial results are known.
alexchry
07/12/2015
11:16
A bit more interest this am, is the message getting through?
diesel
04/12/2015
10:21
Thanks Ace.
pooroldboy55
04/12/2015
10:06
Edison forecasts are slightly ahead of consensus: 2016 revenues £111m, PTP£29.5m EPS 21p. 2016 PER of 15.5 looks pretty good if they hit forecast.
18bt
04/12/2015
10:01
Latest Edison:

"At this stage we maintain our current forecasts but highlight that our 377p/share valuation looks conservative, particularly as we envisage the mid- to long-term earnings story unfolding"

aceuk
03/12/2015
08:59
Yes it fits all the rules I've set myself for my longer term investement but without a return I think the probability of a drop after the high spike is inevitable
so this takes the growth aspect of my rules into play
But that's just my opinion and has been proved wrong on many occasions
Keeping an eye on this for the next few weeks months

janekane
03/12/2015
08:49
Have been thinking the same thing re dividend
pooroldboy55
03/12/2015
08:23
Been following this for a few months after the spike
Profits are rising debt ratio is low
Earnings per share is positive so why are they not paying a divi
I like small caps with potential to grow and this fits the bill but they have enough income to pay the owners a dividend

janekane
Chat Pages: Latest  2130  2129  2128  2127  2126  2125  2124  2123  2122  2121  2120  2119  Older

Your Recent History

Delayed Upgrade Clock